VANGUARD GROUP INC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 88 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 110.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$552,000
+44.1%
3,993,920
+7.1%
0.00%
Q4 2018$383,000
-67.4%
3,727,812
-26.8%
0.00%
Q3 2018$1,174,000
+1.1%
5,095,363
+0.2%
0.00%
Q2 2018$1,161,000
-37.3%
5,083,504
-1.1%
0.00%
Q1 2018$1,851,000
-0.1%
5,141,883
-0.5%
0.00%
Q4 2017$1,853,000
-9.2%
5,170,273
+5.1%
0.00%
Q3 2017$2,041,000
-18.1%
4,917,535
+0.6%
0.00%
Q2 2017$2,492,000
-10.1%
4,887,743
+1.7%
0.00%
Q1 2017$2,773,000
-3.1%
4,807,244
+5.6%
0.00%
Q4 2016$2,862,000
-28.6%
4,554,028
+3.9%
0.00%
Q3 2016$4,011,000
+69.8%
4,381,100
-1.6%
0.00%
Q2 2016$2,362,000
-48.5%
4,451,291
-8.3%
0.00%
Q1 2016$4,583,000
-28.9%
4,851,875
+0.2%
0.00%
Q4 2015$6,443,000
-40.9%
4,844,212
+1.3%
0.00%
Q3 2015$10,905,000
+48.1%
4,782,586
+4.6%
0.00%
Q2 2015$7,361,000
+2.5%
4,571,668
+1.3%
0.00%
Q1 2015$7,178,000
-9.8%
4,514,718
+7.2%
0.00%
-100.0%
Q4 2014$7,960,000
+46.2%
4,211,742
+2.1%
0.00%
Q3 2014$5,444,000
-12.8%
4,124,269
-2.2%
0.00%
Q2 2014$6,242,000
-17.2%
4,217,943
+3.5%
0.00%
-100.0%
Q1 2014$7,542,000
-7.5%
4,076,429
+3.5%
0.00%0.0%
Q4 2013$8,155,000
-19.3%
3,939,767
+3.2%
0.00%0.0%
Q3 2013$10,111,000
+21.0%
3,815,835
+22.0%
0.00%0.0%
Q2 2013$8,354,0003,128,8470.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q2 2014
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders